These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 32058824

  • 1. Inhibition of autophagy improves resistance and enhances sensitivity of gastric cancer cells to cisplatin.
    Hou G, Bai Y, Jia A, Ren Y, Wang Y, Lu J, Wang P, Zhang J, Lu Z.
    Can J Physiol Pharmacol; 2020 Jul; 98(7):449-458. PubMed ID: 32058824
    [Abstract] [Full Text] [Related]

  • 2. Antitumor activity of chloroquine in combination with Cisplatin in human gastric cancer xenografts.
    Zhang HQ, Fang N, Liu XM, Xiong SP, Liao YQ, Jin WJ, Song RF, Wan YY.
    Asian Pac J Cancer Prev; 2015 Jul; 16(9):3907-12. PubMed ID: 25987058
    [Abstract] [Full Text] [Related]

  • 3. Baicalein enhanced cisplatin sensitivity of gastric cancer cells by inducing cell apoptosis and autophagy via Akt/mTOR and Nrf2/Keap 1 pathway.
    Li P, Hu J, Shi B, Tie J.
    Biochem Biophys Res Commun; 2020 Oct 20; 531(3):320-327. PubMed ID: 32800561
    [Abstract] [Full Text] [Related]

  • 4. BI2536, a potent and selective inhibitor of polo-like kinase 1, in combination with cisplatin exerts synergistic effects on gastric cancer cells.
    Lian G, Li L, Shi Y, Jing C, Liu J, Guo X, Zhang Q, Dai T, Ye F, Wang Y, Chen M.
    Int J Oncol; 2018 Mar 20; 52(3):804-814. PubMed ID: 29393385
    [Abstract] [Full Text] [Related]

  • 5. Chloroquine enhances the efficacy of cisplatin by suppressing autophagy in human adrenocortical carcinoma treatment.
    Qin L, Xu T, Xia L, Wang X, Zhang X, Zhang X, Zhu Z, Zhong S, Wang C, Shen Z.
    Drug Des Devel Ther; 2016 Mar 20; 10():1035-45. PubMed ID: 27022243
    [Abstract] [Full Text] [Related]

  • 6. Effect of PLK1 inhibition on cisplatin-resistant gastric cancer cells.
    Chen Z, Chai Y, Zhao T, Li P, Zhao L, He F, Lang Y, Qin J, Ju H.
    J Cell Physiol; 2019 May 20; 234(5):5904-5914. PubMed ID: 30488440
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of MGMT-mediated autophagy suppression decreases cisplatin chemosensitivity in gastric cancer.
    Lei Y, Tang L, Hu J, Wang S, Liu Y, Yang M, Zhang J, Tang B.
    Biomed Pharmacother; 2020 May 20; 125():109896. PubMed ID: 32007918
    [Abstract] [Full Text] [Related]

  • 8. The anti-malarial chloroquine suppresses proliferation and overcomes cisplatin resistance of endometrial cancer cells via autophagy inhibition.
    Fukuda T, Oda K, Wada-Hiraike O, Sone K, Inaba K, Ikeda Y, Miyasaka A, Kashiyama T, Tanikawa M, Arimoto T, Kuramoto H, Yano T, Kawana K, Osuga Y, Fujii T.
    Gynecol Oncol; 2015 Jun 20; 137(3):538-45. PubMed ID: 25842161
    [Abstract] [Full Text] [Related]

  • 9. miR-21 modulates cisplatin resistance of gastric cancer cells by inhibiting autophagy via the PI3K/Akt/mTOR pathway.
    Gu Y, Fei Z, Zhu R.
    Anticancer Drugs; 2020 Apr 20; 31(4):385-393. PubMed ID: 31913198
    [Abstract] [Full Text] [Related]

  • 10. Interference with HMGB1 increases the sensitivity to chemotherapy drugs by inhibiting HMGB1-mediated cell autophagy and inducing cell apoptosis.
    Zhang R, Li Y, Wang Z, Chen L, Dong X, Nie X.
    Tumour Biol; 2015 Nov 20; 36(11):8585-92. PubMed ID: 26040768
    [Abstract] [Full Text] [Related]

  • 11. Proteomics reveals a therapeutic vulnerability via the combined blockade of APE1 and autophagy in lung cancer A549 cells.
    Pan ST, Zhou J, Yang F, Zhou SF, Ren T.
    BMC Cancer; 2020 Jul 08; 20(1):634. PubMed ID: 32641008
    [Abstract] [Full Text] [Related]

  • 12. RKIP promotes cisplatin-induced gastric cancer cell death through NF-κB/Snail pathway.
    Liu H, Li P, Li B, Sun P, Zhang J, Wang B, Jia B.
    Tumour Biol; 2015 Mar 08; 36(3):1445-53. PubMed ID: 25547433
    [Abstract] [Full Text] [Related]

  • 13. Upregulation of miR-34c after silencing E2F transcription factor 1 inhibits paclitaxel combined with cisplatin resistance in gastric cancer cells.
    Zheng H, Wang JJ, Yang XR, Yu YL.
    World J Gastroenterol; 2020 Feb 07; 26(5):499-513. PubMed ID: 32089626
    [Abstract] [Full Text] [Related]

  • 14. Celecoxib enhanced the cytotoxic effect of cisplatin in chemo-resistant gastric cancer xenograft mouse models through a cyclooxygenase-2-dependent manner.
    Xu HB, Shen FM, Lv QZ.
    Eur J Pharmacol; 2016 Apr 05; 776():1-8. PubMed ID: 26879869
    [Abstract] [Full Text] [Related]

  • 15. [Molecular mechanism of cisplatin to enhance the ability of TRAIL in reversing multidrug resistance in gastric cancer cells].
    Zhu X, Zhang K, Wang Q, Chen S, Gou Y, Cui Y, Li Q.
    Zhonghua Zhong Liu Za Zhi; 2015 Jun 05; 37(6):404-11. PubMed ID: 26463141
    [Abstract] [Full Text] [Related]

  • 16. Cucurbitacin B induces autophagy and apoptosis by suppressing CIP2A/PP2A/mTORC1 signaling axis in human cisplatin resistant gastric cancer cells.
    Liu X, Duan C, Ji J, Zhang T, Yuan X, Zhang Y, Ma W, Yang J, Yang L, Jiang Z, Yu H, Liu Y.
    Oncol Rep; 2017 Jul 05; 38(1):271-278. PubMed ID: 28534965
    [Abstract] [Full Text] [Related]

  • 17. Abrogation of Autophagy by Chloroquine Alone or in Combination with mTOR Inhibitors Induces Apoptosis in Neuroendocrine Tumor Cells.
    Avniel-Polak S, Leibowitz G, Riahi Y, Glaser B, Gross DJ, Grozinsky-Glasberg S.
    Neuroendocrinology; 2016 Jul 05; 103(6):724-37. PubMed ID: 26619207
    [Abstract] [Full Text] [Related]

  • 18. Combination treatment of FTY720 and cisplatin exhibits enhanced antitumour effects on cisplatin-resistant non-small lung cancer cells.
    Li Y, Hu T, Chen T, Yang T, Ren H, Chen M.
    Oncol Rep; 2018 Feb 05; 39(2):565-572. PubMed ID: 29207165
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. MiR-30a Decreases Multidrug Resistance (MDR) of Gastric Cancer Cells.
    Li C, Zou J, Zheng G, Chu J.
    Med Sci Monit; 2016 Nov 23; 22():4509-4515. PubMed ID: 27876712
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.